why choose us

First received: December 08, 2022

Clinical Trial: COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Early-Stage Breast Cancer

Study Type: OBSERVATIONAL


Official Title: COGNITION: Comprehensive Assessment of Clinical Features, Genomics and Further Molecular Markers to Identify Patients With Early Breast Cancer for Enrolment on Marker Driven Trials (Molecular Diagnost

Brief Summary: The COGNITION diagnostic platform elucidates the biomarker profile of neoadjuvant chemotherapy-resistant residual bulk tumors in high risk early breast cancer patients.The major goal is to provide a framework for genomic profiling, which serves as infrastructure for systematic biomarker-screening and -stratification for concise therapy-arm allocation in the interventional clinical phase II trial COGNITION-GUIDE (NCT05332561).In patients, who display a poor response to standard-of-care neoadjuvant chemotherapy,…

Read more